Quantcast

Latest News

UVA Health Honored Nationally for High-Quality Heart Imaging

UVA Health’s Heart & Vascular Center is one of just 46 facilities recognized nationally for their longstanding commitment to excellent heart imaging with echocardiograms, which use ultrasound waves to examine the heart’s structure and function.

COVID-19 Discovery Could Protect High-Risk Patients

UVA Health researchers have identified a potential treatment to prevent severe COVID-19 in patients at great risk.

UVA Discovers Anti-Aging Detox Approach That May Help Us Live Longer

University of Virginia scientists have identified a promising approach to delay aging by detoxifying the body of glycerol and glyceraldehyde, harmful by-products of fat that naturally accumulate over time.

University of Missouri researchers develop ultrasoft material for on-skin health devices

Zheng Yan and colleagues from the University of Missouri have designed a soft, pliable material that can barely be felt on a person’s skin, allowing for optimal long-term health monitoring through wearable bioelectronics.

A Gene Involved in Down Syndrome Puts the Brakes on Neurons’ Activity in Mice, New Study Shows

Researchers from the University of Michigan have found that an extra copy of a gene in Down syndrome patients causes improper development of neurons in mice.

‘Binocular’ Treatment Helps with a Common Vision Problem. Sleep Makes It Stick.

Amblyopia, sometimes called lazy eye, is a common vision problem in children and babies, and it’s typically been treated by having the child wear a patch on the stronger eye, with the goal of improving sight for the weaker eye.

Pathogenic Genetic Variations Boost the Risk of H. Pylori-Related Stomach Cancer

A large case-control study by international researchers at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan has found that people who carry certain genetic risk factors for gastric (stomach) cancer have a much greater risk if they have also been infected by the bacterium Helicobacter pylori.

How an Early Mutation in the Covid-19 Virus Helped It Spread So Fast

Molecular modeling suggests structural consequences of an early protein mutation that promoted viral transmission

The Right Cocktail of Gut Enzymes Can Stop C. diff in its Tracks

Not all probiotics are created equal. In a new study, researchers found that certain enzymes within a class known as bile salt hydrolases (BSHs) can restrict Clostridioides difficile (C. diff.) colonization by both altering existing bile acids and by creating a new class of bile acids within the gut’s microbial environment.

Health Coaching Program Shows Promise for Managing Student Stress

North Carolina State University researchers found in a recent study that before disruptions from the COVID-19 outbreak, a group of college students had higher average physical activity in a pilot wellness program that combined health coaching with exercise and sleep tracking.

COVID Fears and Long-Term Planning Play Key Roles in Vaccine Hesitancy

A recent study finds that concerns about the health effects of COVID-19 are a key variable in determining whether people are hesitant to get vaccinated against the virus.

HIV And Hepatitis C Virus Monitoring Needs to Increase to Achieve Global Elimination Goals

Countries must intensify efforts to track HIV and hepatitis C virus (HCV) incidence among people who inject drugs, and to prioritise this group in prevention and elimination work, according to new University of Bristol-led research, published online in The Lancet Gastroenterology & Hepatology.

Providing Free School Meals to All Secondary Pupils Is Feasible and Acceptable, Finds Study

Providing free school meals to all secondary pupils is feasible and acceptable, and brings many potential benefits, finds a new University of Bristol-led study of a pilot scheme in the London Borough of Hammersmith and Fulham, published today [22 March].

Genetic Causes of Three Previously Unexplained Rare Diseases Identified

Using a new computational approach developed to analyse large genetic datasets from rare disease cohorts, researchers at the Icahn School of Medicine at Mount Sinai and colleagues including the University of Bristol, have discovered previously unknown genetic causes of three rare conditions:

Researcher: 'We’re hoping to identify a way to counteract that suppressive response, so that we can reactivate the lung-tumor-targeting T cells.'

New research at the Massachusetts Institute of Technology (MIT) has discovered that bacteria present in the lungs create an environment that suppresses the activation of cancer-killing T cells in the nearby lymph nodes, making immunotherapy treatments less effective.

Delaying Treatment for Localised Prostate Cancer Does Not Increase Mortality Risk, Trial Shows

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind today.

Genetic Variation That Protected Against Black Death Still Helps Protect Against Infection but Increases Autoimmune Disease

The same genetics that helped some of our ancestors fight the plague is still likely to be at work in our bodies today, potentially providing some of the population with extra protection against respiratory diseases such as COVID-19, according to research led by scientists at University of Bristol.

New Guidance on Hip Fracture Services Will Improve Recovery for Thousands of Patients

A new 'toolkit' for senior doctors and hospital managers, that will help make changes to their organisational arrangements and improve the quality of hip fracture care across the UK has been launched by The Royal Osteoporosis Society (ROS) in collaboration with researchers from the University of Bristol.

New Tool to Value Health of Urban Developments

A new tool to value the health effects of urban development proposals has been revealed by researchers at the Universities of Bristol and Bath and published in Frontiers in Public Health.

Brain Cancer: Serious Consequences for Young Survivors

From neurological problems to hearing loss and infertility, survivors of medulloblastoma, an aggressive form of brain cancer, are left with severe physical and cognitive impairments and have an overall mortality rate 21 times higher than the general population.